Ketogenic Diet: from the Historical Records to Use in Elite Athletes.


Journal

Current nutrition reports
ISSN: 2161-3311
Titre abrégé: Curr Nutr Rep
Pays: United States
ID NLM: 101587480

Informations de publication

Date de publication:
12 2019
Historique:
pubmed: 13 11 2019
medline: 5 8 2020
entrez: 13 11 2019
Statut: ppublish

Résumé

To review the available literature/evidence on low carbohydrate/high fat (LCHF) and low carbohydrate ketogenic (LCKD) diets' effects on human athletic performance and to provide a brief review of the physiology and history of energy systems of exercise. Multiple studies have been conducted in an attempt to answer this question, many within the last 3-5 years. Studies are heterogenous in design, intervention, and outcome measures. Current available data show that LCHF and LCKD do not significantly enhance or impair performance in endurance or strength activities. However, there is a trend towards improved body composition (greater percent lean body mass) across multiple studies. While this may not translate to enhanced performance in the primarily laboratory conditions in the reviewed studies, there could be a benefit in sports in which an athlete's strength-to-weight ratio is a significant determinant of outcome.

Identifiants

pubmed: 31713719
doi: 10.1007/s13668-019-00294-0
pii: 10.1007/s13668-019-00294-0
doi:

Types de publication

Historical Article Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

340-346

Références

Sports (Basel). 2018 Jan 09;6(1):null
pubmed: 29910305
Sports Med. 2018 Oct;48(10):2219-2226
pubmed: 29777386
Metabolism. 2002 Jun;51(6):678-90
pubmed: 12037719
Exerc Sport Sci Rev. 2015 Jul;43(3):153-62
pubmed: 25906427
J Clin Invest. 1980 Nov;66(5):1152-61
pubmed: 7000826
Eur J Appl Physiol Occup Physiol. 1981;46(3):211-9
pubmed: 7195804
Biochem J. 1920 Jul;14(3-4):290-363
pubmed: 16742941
Acta Physiol Scand. 1977 Jan;99(1):91-7
pubmed: 190867
Nutrients. 2014 Jun 27;6(7):2493-508
pubmed: 24979615
Metabolism. 1983 Aug;32(8):769-76
pubmed: 6865776
J Clin Invest. 1981 Aug;68(2):399-404
pubmed: 7263859
J Strength Cond Res. 2018 Nov;32(11):3103-3111
pubmed: 29076962
Acta Physiol Scand. 1967 Oct-Nov;71(2):140-50
pubmed: 5584523
Med Sci Sports Exerc. 1989 Oct;21(5):550-7
pubmed: 2691816
J Strength Cond Res. 2018 Dec;32(12):3373-3382
pubmed: 30335720
Metabolism. 2018 Apr;81:25-34
pubmed: 29108901
Med Sci Sports Exerc. 2003 Jun;35(6):952-60
pubmed: 12783043
Metabolism. 1999 Dec;48(12):1509-17
pubmed: 10599981
J Appl Physiol Respir Environ Exerc Physiol. 1984 Apr;56(4):831-8
pubmed: 6373687
J Physiol. 2017 May 1;595(9):2785-2807
pubmed: 28012184
J Appl Physiol (1985). 1994 Jun;76(6):2253-61
pubmed: 7928844
J Int Soc Sports Nutr. 2012 Jul 26;9(1):34
pubmed: 22835211
J Int Soc Sports Nutr. 2017 Jul 12;14:22
pubmed: 28706467
J Appl Physiol (1985). 1990 Oct;69(4):1276-82
pubmed: 2262444
J Strength Cond Res. 2017 Apr 07;:null
pubmed: 28399015
Sports Med. 2015 Nov;45 Suppl 1:S33-49
pubmed: 26553488
J Appl Physiol (1985). 2006 Jan;100(1):7-8
pubmed: 16357078
Med Sci Sports Exerc. 2018 Mar;50(3):570-579
pubmed: 29112626
Biochem J. 1937 Apr;31(4):645-60
pubmed: 16746382
Eur J Appl Physiol Occup Physiol. 1994;69(4):287-93
pubmed: 7851362

Auteurs

Matthew B Kaspar (MB)

Department of Internal Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University Medical Center, 1200 East Broad Street, P.O. Box 980509, Richmond, VA, 23298, USA. matthew.kaspar@vcuhealth.org.

Kerstin Austin (K)

Division of Gastroenterology and Hepatology, University of Wisconsin School of Medicine and Public Health, Madison, WI, 53705, USA.

Martin Huecker (M)

Department of Emergency Medicine, University of Louisville School of Medicine, Louisville, KY, USA.

Menaka Sarav (M)

Division of Nephrology and Hypertension, NorthShore University Health System, University of Chicago, Chicago, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH